BRD2 and benign prostatic hyperplasia: Interestingly, Kiss1 is approximately fourfold higher in NAT BPH/5 vs. NAT C57 eIS at e4.5 (Figure 3A; p = 0.013), while eIS Kiss1r is not different between NAT BPH/5 and NAT C57 females (Supplementary Figure S1F; p > 0.05).